6月9日，英矽智能盘中下跌5.43%，报33.8港元/股，成交额1.0亿港元。消息面上，公司基石投资者及员工限售股禁售期将于6月29日届满，届时约4.53亿股面临解禁，占总股本81.25%，市场对潜在减持压力的担忧持续加剧抛售。与此同时，生命科学工具和服务板块今日整体走弱，药明康德跌6.35%、金斯瑞生物科技跌5.13%、药明合联跌4.66%、药明生物跌4.54%、晶泰控股跌3.81%，行业共振进一步放大跌幅。此外，公司此前澄清无阿布扎比二次上市计划，叠加近一个月累计跌幅已超40%，市场情绪持续低迷。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.